BVCF
Overview
BVCF is a venture capital firm founded in 2005 that focuses on life sciences and healthcare sectors in China. The firm invests across China and the United States including healthcare services, innovative biologic, in-vitro diagnostics (molecular diagnostics), high value medical equipment and consumables and medical big data and mobile medicine .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BioNTech SE | Jul 2019 | Series B | - |
| Shandong Boan Biotechnology | Jan 2021 | Growth Equity | Co-investor |
| Mighty Therapeutics | Jun 2018 | Convertible Debt | Co-investor |
| Drug Farm | Jul 2026 | Series D | Co-investor |
| DiaCarta, Inc. | Jan 2015 | Series A | Lead |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is BVCF based?
BVCF is headquartered in Shanghai, Shanghai, China.
When was BVCF founded?
BVCF was founded in 2005.
How many portfolio companies does BVCF have?
BVCF has 6 portfolio companies in Caplight's dataset.
What are some companies in BVCF's portfolio?
Portfolio companies visible on Caplight include BioNTech SE, Shandong Boan Biotechnology, Mighty Therapeutics, Drug Farm, DiaCarta, Inc..
What was BVCF's most recent investment shown here?
BVCF's most recent investment in this portfolio sample was in Drug Farm in 2026.
What sectors does BVCF focus on?
BVCF focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does BVCF focus on?
BVCF typically invests at the MultiStage stage.
What is BVCF's AUM?
BVCF's assets under management are estimated between $500.0M and $1.0B.